Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

4-Week Multicenter, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Safety and Efficacy Study of PUR 0110 (Thykamine™) Cream Applied Twice Daily in Mild-to-Moderate Atopic Dermatitis

Next Previous
X
Search
Trial Profile

4-Week Multicenter, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Safety and Efficacy Study of PUR 0110 (Thykamine™) Cream Applied Twice Daily in Mild-to-Moderate Atopic Dermatitis

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 19 May 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Thykamine (Primary)
  • Indications Atopic dermatitis
  • Focus Therapeutic Use
  • Sponsors PurGenesis Technologies

    • Most Recent Events

    • 16 May 2023 According to a Devonian media release, results of this study will be presented at the upcoming 25th World Congress of Dermatology to be held in Singapore from July 3rd to 8th.
    • 12 Oct 2022 According to a Devonian media release, results from this trial will be presented at the upcoming 6th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases ("ADDDS") 2022.
    • 06 Oct 2022 According to a Devonian media release, results from the trial are published in the Journal of Drugs in Dermatology (JDD).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top